Selexis
Plan-les-ouates
About Selexis
Selexis is a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell line generation, providing unparalleled proprietary technology and the highly-specialized expertise that is necessary to translate scientific innovation into life-saving medicines for patients.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $67.5K
- Funding stage: M&A
- Last round: Grant (May 2015)
- Website: selexis.com
- Phone: (022) 308-9360
Industries & Categories
Biotechnology, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/selexis-3557802 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.